Study: Nalls, 2014

Population Ethnicity Diagnosis Source # Cases (% women) # Controls (% women) AAO (sd) AAO range AAE (sd) AAE range Ctrl age (sd) Ctrl age range # Polymorphisms
USA (PROGENI-GenePD) C UKPDSBB CL 828 (40%) 852 (60%) 62 (11) - - - 55 (13) - 9,762

Polymorphisms in this population [-]

Polymorphism Location (hg19) Gene Allele contrast Ethnicity # Studies # Samples 1000G CEU 1000G CHB+JPT Meta OR (95%CI) I2 (95%CI) Meta P-value
rs9925964 chr16:31129895 KAT8 G vs. A All: C 15 108,990 0.442 (G) 0.092 (A) 1.09 (1.06-1.13) 27 (0-61) 4.97e-08
rs1978487 chr16:31129942 KAT8 C vs. T All: C 15 108,990 0.45 (C) 0.092 (T) 1.09 (1.05-1.12) 28 (0-61) 1.99e-07
rs1978485 chr16:31131121 KAT8 T vs. C All: C 15 108,990 - - 0.92 (0.89-0.95) 27 (0-60) 1.56e-07
rs4889620 chr16:31131174 KAT8 A vs. G All: C 15 108,990 0.45 (A) 0.092 (G) 1.09 (1.06-1.13) 27 (0-61) 4.91e-08
rs4527034 chr16:31131614 KAT8 A vs. G All: C 15 108,990 0.458 (A) 0.092 (G) 1.09 (1.06-1.13) 28 (0-61) 5.60e-08
rs11865499 chr16:31132250 KAT8 G vs. A All: C 15 108,990 0.2 (G) 0.092 (G) 0.92 (0.89-0.96) 31 (0-63) 1.37e-05
rs28725459 chr16:31132662 KAT8 G vs. A All: C 15 108,990 - - 1.08 (1.04-1.12) 30 (0-62) 1.55e-05
rs59735493 chr16:31133100 KAT8 A vs. G All: C 15 108,990 0.2 (A) 0.092 (A) 0.92 (0.89-0.96) 31 (0-63) 1.37e-05
rs1060506 chr16:31133449 KAT8 T vs. C All: C 15 108,990 0.2 (T) 0.092 (T) 0.92 (0.89-0.96) 31 (0-63) 1.34e-05
rs61320757 chr16:31134059 KAT8 G vs. A All: C 15 108,990 - - 1.08 (1.04-1.12) 25 (0-60) 4.11e-05
rs889548 chr16:31137712 KAT8 T vs. C All: C 14 106,157 0.45 (T) 0.092 (C) 1.09 (1.06-1.13) 33 (0-65) 1.68e-07
rs1549293 chr16:31141993 KAT8 T vs. C All: C 15 108,990 0.45 (T) 0.092 (C) 1.09 (1.06-1.13) 30 (0-63) 7.34e-08
rs12597511 chr16:31145219 PRSS8 T vs. C All: C 15 108,990 0.458 (T) 0.092 (C) 1.10 (1.06-1.13) 34 (0-64) 7.40e-08
rs2855475 chr16:31147548 PRSS8 [+465bp] G vs. A All: C 15 108,990 0.45 (G) 0.092 (A) 1.09 (1.06-1.13) 32 (0-63) 6.90e-08
rs9972727 chr16:31149142 PRSS36 [-1104bp] G vs. A All: C 15 108,990 - - 0.91 (0.88-0.94) 34 (0-64) 7.38e-08
rs1549299 chr16:31154146 PRSS36 G vs. A All: C 15 108,990 0.208 (G) 0.067 (G) 0.92 (0.89-0.96) 34 (0-65) 1.81e-05
rs78924645 chr16:31154358 PRSS36 A vs. G All: C 15 108,990 0.208 (A) 0.058 (A) 0.93 (0.89-0.96) 32 (0-63) 1.38e-04
rs55667375 chr16:31155458 PRSS36 T vs. C All: C 15 108,990 0.208 (T) 0.075 (T) 0.92 (0.89-0.96) 30 (0-62) 6.23e-05
rs9939286 chr16:31162303 PRSS36 [+888bp] T vs. G All: C 15 108,990 0.333 (T) 0.117 (T) 0.92 (0.88-0.95) 27 (0-61) 1.83e-05
rs7190802 chr16:31163531 PRSS36 [+2116bp] G vs. T All: C 15 108,990 0.325 (G) 0.108 (G) 0.92 (0.88-0.96) 28 (0-61) 1.98e-05
rs57611503 chr16:31165795 PRSS36 [+4380bp] G vs. A All: C 15 108,990 0.475 (G) 0.117 (G) 0.92 (0.88-0.95) 32 (0-63) 1.65e-05
rs12102776 chr16:31166028 PRSS36 [+4613bp] T vs. C All: C 15 108,990 0.342 (T) 0.108 (T) 0.92 (0.89-0.96) 25 (0-60) 4.98e-05
rs4889625 chr16:31167179 PRSS36 [+5764bp] G vs. A All: C 15 108,990 - - 1.08 (1.04-1.13) 25 (0-60) 8.15e-05
rs62053177 chr16:31513509 C16orf58 T vs. C All: C 15 108,990 0.075 (T) - 0.92 (0.84-0.99) 0 (0-53) 0.035
rs9922304 chr16:31605067 intergenic C vs. T All: C 15 108,990 0.067 (C) 0.275 (C) 0.92 (0.86-0.98) 0 (0-35) 0.014
rs61518410 chr16:31610882 intergenic T vs. C All: C 15 108,990 0.075 (T) 0.275 (T) 0.92 (0.85-0.98) 0 (0-38) 0.012
rs11865800 chr16:31613277 intergenic T vs. C All: C 15 108,990 0.075 (T) 0.283 (T) 0.92 (0.85-0.98) 0 (0-38) 0.012
rs114026251 chr16:48007906 intergenic T vs. C All: C 12 99,075 0.025 (T) - 1.27 (1.12-1.44) 53 (9-76) 1.78e-04
rs115347792 chr16:48064468 intergenic A vs. G All: C 13 99,521 0.033 (A) - 1.25 (1.12-1.39) 46 (0-71) 7.59e-05
rs11648013 chr16:49722411 ZNF423 G vs. A All: C 15 108,990 0.283 (G) 0.458 (G) 1.07 (1.03-1.11) 0 (-) 2.14e-04
rs2356619 chr16:49729630 ZNF423 G vs. A All: C 15 108,990 0.292 (G) 0.5 (G) 1.08 (1.04-1.12) 0 (0-9) 9.02e-05
rs17271951 chr16:52538040 TOX3 C vs. T All: C 15 108,990 0.25 (C) 0.225 (C) 1.08 (1.04-1.12) 0 (0-54) 3.08e-05
rs35668161 chr16:52538825 TOX3 C vs. A All: C 15 108,990 - - 0.92 (0.89-0.96) 1 (0-54) 2.96e-05
rs12600239 chr16:52538900 TOX3 C vs. T All: C 15 108,990 - - 0.93 (0.89-0.96) 0 (0-52) 4.24e-05
rs7500427 chr16:52545277 TOX3 G vs. A All: C 15 108,990 - - 0.92 (0.89-0.96) 0 (0-51) 3.25e-05
rs9936081 chr16:52549646 TOX3 A vs. G All: C 15 108,990 0.25 (A) 0.458 (A) 1.08 (1.04-1.12) 0 (0-52) 3.56e-05
rs1345388 chr16:52556293 TOX3 C vs. T All: C 15 108,990 0.242 (C) 0.45 (C) 1.08 (1.04-1.12) 0 (0-51) 3.06e-05
rs12918816 chr16:52560213 TOX3 A vs. G All: C 15 108,990 0.25 (A) 0.475 (A) 1.08 (1.04-1.12) 0 (0-50) 2.11e-05
rs9921569 chr16:52572029 TOX3 C vs. T All: C 15 108,990 0.258 (C) 0.475 (C) 1.08 (1.04-1.12) 0 (0-49) 2.25e-05
rs35850695 chr16:52574343 TOX3 A vs. G All: C 15 108,990 0.258 (A) 0.258 (A) 1.08 (1.05-1.12) 0 (0-48) 1.47e-05
rs4784223 chr16:52575907 TOX3 G vs. A All: C 15 108,990 0.258 (G) 0.475 (G) 1.08 (1.04-1.12) 0 (0-49) 2.25e-05
rs8045285 chr16:52579986 TOX3 G vs. A All: C 15 108,990 0.208 (G) 0.475 (G) 1.08 (1.04-1.12) 0 (0-42) 3.40e-05
rs3095602 chr16:52580500 TOX3 A vs. G All: C 15 108,990 0.242 (A) - 1.08 (1.04-1.12) 0 (0-44) 2.90e-05
rs12930156 chr16:52581424 TOX3 T vs. C All: C 15 108,990 0.242 (T) 0.367 (C) 1.08 (1.04-1.12) 0 (0-46) 1.92e-05
rs28463809 chr16:52583054 TOX3 [+1340bp] T vs. G All: C 15 108,990 0.242 (T) 0.367 (G) 1.08 (1.04-1.11) 0 (0-43) 4.65e-05
rs4784226 chr16:52583143 TOX3 [+1429bp] T vs. C All: C 15 108,990 0.208 (T) 0.25 (T) 1.10 (1.05-1.14) 0 (0-43) 3.37e-06
rs3095606 chr16:52584173 TOX3 [+2459bp] G vs. A All: C 15 108,990 0.242 (G) 0.367 (A) 1.08 (1.04-1.12) 0 (0-41) 4.20e-05
rs3095607 chr16:52584295 TOX3 [+2581bp] G vs. T All: C 15 108,990 0.242 (G) 0.367 (T) 1.08 (1.04-1.11) 0 (0-43) 4.87e-05
rs3112578 chr16:52585440 TOX3 [+3726bp] C vs. T All: C 15 108,990 0.217 (C) 0.475 (C) 1.09 (1.05-1.13) 0 (0-47) 7.96e-06
rs3803662 chr16:52586341 TOX3 [+4627bp] A vs. G All: C 15 108,990 0.242 (A) 0.367 (G) 1.07 (1.04-1.11) 0 (0-45) 6.70e-05